ClinicalTrials.gg
RecruitingNCT07747441Updated Aug 10, 2026

Perfusion Index and Spinal Hypotension in Day-Case Knee Arthroscopy

An observational study in Hypotension, Spinal Anesthesia Induced Hypotension and Anesthesia, Spinal, sponsored by Ankara Etlik City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by Ankara Etlik City Hospital · Observational

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 96 studies in Hypotension with a site in Turkey — 34 open to participants now, 35 under way, none of them phase 3. Hypotension · Turkey.

Planned enrollment
11th of 62
150 · median 100
Started
2026
with 23 others
Observational
62 of 96
24 open now
Primary completion
2026-12
later than 20 of 34 live
Registered
83rd of 96
by date

Among the 96 studies in Hypotension with a site in Turkey, this one is the 11th largest by planned enrollment of the 62 observational ones that give a count, is one of 24 that started in 2026, is one of 62 observational ones, reaches primary completion later than 20 of the 34 other live ones, and was the 83rd registered.

Hypotension

892 studies on the registry are indexed under Hypotension; 199 are open to participants now.

Browse Hypotension studies →

Open to participants now

34 of the 96 studies in Hypotension with a site in Turkey are open now. Recruiting first, the newest first:

28 more — sign in →

All 34 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Hypotension with a site in Turkey, or all of them as a file.
02

Study summary

This prospective observational study aims to investigate the role of the baseline perfusion index (PI) in predicting spinal anesthesia-induced hypotension (SAIH) in ASA I-II patients undergoing day-case knee arthroscopy.

Spinal anesthesia is a widely preferred technique for lower extremity surgeries, including knee arthroscopy. However, sympathetic blockade during spinal anesthesia frequently leads to significant hemodynamic instability, particularly hypotension, which can result in adverse perioperative outcomes. While age and baseline blood pressure are traditional risk factors, they often fail to accurately predict the onset of hypotension in healthy populations. The perfusion index (PI), a non-invasive parameter measured via pulse oximetry, reflects peripheral vascular tone and baseline sympathetic activity. An elevated baseline PI indicates baseline vasodilation and a higher susceptibility to sympathectomy, potentially offering an early and non-invasive prediction of SAIH before the hemodynamic collapse occurs.

The primary outcome of the study is the incidence of spinal anesthesia-induced hypotension (defined as a mean arterial pressure \< 65 mmHg or a decrease in systolic blood pressure > 25% from baseline). Secondary outcomes include the onset time of sensory block, and intraoperative ephedrine and fluid requirements.

03

Conditions studied

  • Hypotension
  • Spinal Anesthesia Induced Hypotension
  • Anesthesia, Spinal
  • Arthroscopy

Browse trials for

Keywords

  • Perfusion Index
  • Spinal Anesthesia
  • Hypotension
  • Knee Arthroscopy
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients with American Society of Anesthesiologists physical status I or II who are scheduled for elective knee arthroscopy under spinal anesthesia at Etlik City Hospital will be consecutively screened for participation.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 18-65
  • Having an ASA Score of I-II
  • Including data collection of parts that underwent knee arthroscopy

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 and over 65 years of age
  • Patients with ASA Score III and above
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Spinal anesthesia-induced hypotension

    Defined as a mean arterial pressure \< 65 mmHg or a decrease in systolic blood pressure \> 25% from baseline

    Time frame: During the surgery

Secondary outcomes

  1. Investigation of Sensory Block Kinetics

    Time to reach the T10 sensory dermatome

    Time frame: Periprocedural

  2. Vasopressor Consumption

    Total amount of rescue vasopressor (Ephedrine) consumed to treat hypotension during the intraoperative period

    Time frame: During the surgery

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.

Of 149 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 4 months is below that.

Counting every sponsor, half of 154 studies reached it within 11 months; a quarter within 5 and three quarters within 25.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2026
First posted
Aug 5, 2026
StartActual
Aug 6, 2026
Primary completionEst.
Dec 14, 2026
CompletionEst.
Dec 28, 2026
Last update
Aug 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07747441
Responsible party
İbrahim Topcu (Principal Investigator, Ankara Etlik City Hospital) — Principal investigator
First posted
Aug 5, 2026
Start date
Aug 6, 2026
Primary completion
Dec 14, 2026 (estimated)
Completion
Dec 28, 2026 (estimated)
Last update
Aug 10, 2026

Study contacts

İbrahim MD Topcu, MD
Contact
ibrahimtpc78@gmail.com
05437860316
Musa Ass. Prof Zengin, Ass. Prof
Contact
musazengin@gmail.com
05071302750

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion